About 400 reports

  • TYPES OF LUNG CANCER
  • LUNG CANCER THERAPEUTICS MARKET IN EMEA
  • Lung Cancer
  • AstraZeneca PLC
  • Celgene Corporation
  • Eli Lilly & Co.
  • Hoffmann-La Roche Inc.
  • RISING INCIDENCE OF LUNG CANCER
  • MARKET SIZE: GLOBAL LUNG CANCER LIQUID BIOPSY MARKET
  • Lung Cancer
  • Biocept, Inc.
  • Exosome Diagnostics, Inc.
  • F. Hoffmann-La Roche Ltd.
  • QIAGEN N.V.
  • RISK FACTORS AND COMORBIDITIES FOR LUNG CANCER
  • DEFINITIONS USED IN THE AJCC LUNG CANCER STAGING SYSTEM
  • Lung Cancer
  • Eli Lilly & Co.
  • Merck & Co., Inc.
  • Novartis AG
  • Pfizer Inc.
  • NSCLC Therapeutics Market, Australia, Age-Specific Incidence Rate (per 100,000),
  • NSCLC Therapeutics Market, Japan, Market Forecast, 2016-2023
  • Lung Cancer
  • AstraZeneca PLC
  • Eli Lilly & Co.
  • Novartis AG
  • Roche Group

Key Features of the Report: - Non-Small Cell Lung Cancer Patient Flow - Non-Small Cell Lung Cancer Prevalence - Non-Small Cell Lung Cancer Diagnosed Patients - Non-Small Cell Lung Cancer Treated Patients

  • Lung Cancer
  • Europe
  • France
  • World
  • Forecast
  • Risk Factors and Comorbidities Associated with SCLC
  • 2.3 UPCOMING REPORTS
  • Lung Cancer
  • Japan
  • United Kingdom
  • Forecast
  • GlobalData's company

Lung Cancer Market Forecast ($), Japan, 2015 – 2020 The latest research from Fore Pharma, Global Lung Cancer Market and Competitive Landscape Highlights – 2016, provides comprehensive insights into Lung Cancer pipeline products, Lung

  • Lung Cancer
  • France
  • Germany
  • Italy
  • Market Size

Non-small Cell Lung Cancer (NSCLC) Therapeutics Market Analysis Table of Content Chapter ## Research Methodology ##. ## Information Procurement ##. ## Data Analysis Chapter ## Executive Summary ##. ## Market Snapshot Chapter ## Non-small Cell Lung Cancer Therapeutics Marke

  • Cancer
  • Lung Cancer
  • Therapy
  • World
  • Forecast

Non-Small Cell Lung Cancer (NSCLC) Drugs Market Forecast 2017-2027 ##.

  • Cancer
  • Lung Cancer
  • Pathology
  • World
  • Forecast

Lung Cancer Vaccine Mechanism ##. ## Mechanism of Lung Cancer Vaccination ##. ## Rationale for Using Lung Cancer Vaccines ##. ##. ## Regulatory T- Lymphocytes (Tregs) ##. ##. ## Macrophages ##.

  • Lung Cancer
  • Therapy
  • Vaccine
  • World
  • Forecast

Non-Small Cell Lung Cancer Market Forecast ($), Japan, 2015 – 2020 The latest research from Fore Pharma, Global Non-Small Cell Lung Cancer Market and Competitive Landscape Highlights – 2016, provides comprehensive insights into Non-Small Cell Lung

  • Lung Cancer
  • France
  • Germany
  • Italy
  • Market Size

Depending on original data sources used, the definition of non-small cell lung cancer (NSCLC) drugs is established.

  • Cancer
  • Lung Cancer
  • Demand

Key Features of the Report: - Small Cell Lung Cancer Patient Flow - Small Cell Lung Cancer Prevalence - Small Cell Lung Cancer Diagnosed Patients - Small Cell Lung Cancer Treated Patients

  • Lung Cancer
  • Europe
  • France
  • Germany
  • Forecast
  • GENE MUTATIONS IN NON-SMALL CELL LUNG CANCER
  • RISK FACTORS FOR NON-SMALL CELL LUNG CANCER
  • Lung Cancer
  • AstraZeneca PLC
  • Celgene Corporation
  • Hoffmann-La Roche Inc.
  • Pfizer Inc.

Key Features of the Report: - Non-Small Cell Lung Cancer Patient Flow - Non-Small Cell Lung Cancer Prevalence - Non-Small Cell Lung Cancer Diagnosed Patients - Non-Small Cell Lung Cancer Treated Patients

  • Lung Cancer
  • Europe
  • France
  • Germany
  • Forecast

Non-small cell lung cancer is a type of lung cancer which accounted ##-##% of all lung cancers.

  • Cancer
  • Lung Cancer
  • Pathology
  • World
  • Market Size

Lung cancer is classified into three main types: non-small cell lung cancer (NSCLC), small cell lung cancer, and lung carcinoid tumor.

  • Cancer
  • Lung Cancer
  • Pathology
  • China
  • Forecast

Non-Small Cell Lung Cancer - Epidemiology Forecast to 2027 ##.

  • Lung Cancer
  • France
  • Germany
  • Italy
  • Spain

There are two types of lung cancer: small cell lung cancer (SCLC), which is around ##%; and non-small cell lung cancer (NSCLC), which is ##% of the total lung cancers.

  • Cancer
  • Lung Cancer
  • Pathology
  • World

Non-Small Cell Lung Cancer : ##MM Market Analysis ##. ##. ##MM Market Size of Non-Small Cell Lung Cancer ##. ##. ##MM Percentage Share of drugs marketed for Non-Small Cell Lung Cancer ##. ##. ##MM Market Sales of Non-Small Cell Lung

  • Cancer
  • Lung Cancer
  • Pathology

Lung Cancer Market Forecast ($), UK, 2015 – 2020 The latest research from Fore Pharma, Europe Lung Cancer Market and Competitive Landscape Highlights – 2016, provides comprehensive insights into Lung Cancer pipeline products, Lung

  • Lung Cancer
  • Europe
  • France
  • Germany
  • Market Size
  • 4.1 DISEASE BACKGROUND
  • 4.4 FORECAST METHODOLOGY
  • Lung Cancer
  • Bristol-Myers Squibb Company
  • GlobalData's company
  • Immunomedics, Inc.
  • MolMed S.p.A.
  • GLOBAL LUNG CANCER CASES BY TYPE
  • 3.7 ONCOCYTE (LUNG CANCER TEST)
  • Cancer
  • Lung Cancer
  • World
  • Market Size
  • MetaStat, Inc.

Japan Lung Cancer Market and Competitive Landscape Highlights – 2016 ##) Disease Overview a) Etiology b) Pathophysiology c) Diagnosis ##) Lung Cancer Treatments ##) Lung Cancer Pipeline ##) Japan Lung Cancer Epidemiology ##) Marketed Drugs fo

  • Cancer
  • Lung Cancer
  • Pathology
  • Japan
  • Market Size

UK Lung Cancer Market and Competitive Landscape Highlights – 2016 ##) Disease Overview a) Etiology b) Pathophysiology c) Diagnosis ##) Lung Cancer Treatments ##) Lung Cancer Pipeline ##) UK Lung Cancer Epidemiology ##) Marketed Drugs for

  • Cancer
  • Lung Cancer
  • Pathology
  • United Kingdom
  • Market Size

Italy Lung Cancer Market and Competitive Landscape Highlights – 2016 ##) Disease Overview a) Etiology b) Pathophysiology c) Diagnosis ##) Lung Cancer Treatments ##) Lung Cancer Pipeline ##) Italy Lung Cancer Epidemiology ##) Marketed Drugs fo

  • Cancer
  • Lung Cancer
  • Pathology
  • Italy
  • Market Size

Germany Lung Cancer Market and Competitive Landscape Highlights – 2016 ##) Disease Overview a) Etiology b) Pathophysiology c) Diagnosis ##) Lung Cancer Treatments ##) Lung Cancer Pipeline ##) Germany Lung Cancer Epidemiology ##) Marketed Drug

  • Cancer
  • Lung Cancer
  • Pathology
  • Germany
  • Market Size

France Lung Cancer Market and Competitive Landscape Highlights – 2016 ##) Disease Overview a) Etiology b) Pathophysiology c) Diagnosis ##) Lung Cancer Treatments ##) Lung Cancer Pipeline ##) France Lung Cancer Epidemiology ##) Marketed Drugs

  • Cancer
  • Lung Cancer
  • Pathology
  • France
  • Market Size

Spain Lung Cancer Market and Competitive Landscape Highlights – 2016 ##) Disease Overview a) Etiology b) Pathophysiology c) Diagnosis ##) Lung Cancer Treatments ##) Lung Cancer Pipeline ##) Spain Lung Cancer Epidemiology ##) Marketed Drugs fo

  • Cancer
  • Lung Cancer
  • Pathology
  • Spain
  • Market Size

US Lung Cancer Market and Competitive Landscape Highlights – 2016 ##) Disease Overview a) Etiology b) Pathophysiology c) Diagnosis ##) Lung Cancer Treatments ##) Lung Cancer Pipeline ##) US Lung Cancer Epidemiology ##) Marketed Drugs for

  • Cancer
  • Lung Cancer
  • Pathology
  • Market Size